1. Home
  2. ABAT vs PRTA Comparison

ABAT vs PRTA Comparison

Compare ABAT & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Battery Technology Company

ABAT

American Battery Technology Company

HOLD

Current Price

$4.18

Market Cap

525.1M

ML Signal

HOLD

Logo Prothena Corporation plc

PRTA

Prothena Corporation plc

HOLD

Current Price

$8.88

Market Cap

538.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABAT
PRTA
Founded
2011
2012
Country
United States
Ireland
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
525.1M
538.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ABAT
PRTA
Price
$4.18
$8.88
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$18.86
AVG Volume (30 Days)
7.4M
500.4K
Earning Date
02-05-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,453,244.00
$11,786,000.00
Revenue This Year
$145.40
N/A
Revenue Next Year
N/A
$1,183.79
P/E Ratio
N/A
N/A
Revenue Growth
976.80
N/A
52 Week Low
$0.86
$4.32
52 Week High
$11.49
$16.67

Technical Indicators

Market Signals
Indicator
ABAT
PRTA
Relative Strength Index (RSI) N/A 44.64
Support Level N/A $8.23
Resistance Level N/A $9.05
Average True Range (ATR) 0.00 0.53
MACD 0.00 -0.07
Stochastic Oscillator 0.00 28.26

Price Performance

Historical Comparison
ABAT
PRTA

About ABAT American Battery Technology Company

American Battery Technology Co is an integrated critical battery minerals company that develops technologies for both primary battery minerals manufacturing and lithium-ion battery recycling. It operates battery recycling facilities that process materials from electric vehicle batteries, stationary battery energy storage systems, and consumer electronics. Additionally, the company advances lithium production projects using proprietary technology to produce battery-grade lithium hydroxide. It generates revenue mainly from its recycling operations and is expanding capacity with strategic partnerships and government grants. The company's activities focus on creating a closed-loop battery materials supply chain to support sustainable manufacturing in the United States.

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

Share on Social Networks: